Obstetrics & Gynecology · Philadelphia, PA
NPI
1982660643
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
216 N Broad St, 4th Floor
Philadelphia, PA, 19102
Phone (215) 762-3600
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
2,123 services
Medicare patients, 2024
308
Average age 73
Drug cost, 2024
$142K
1,359 prescriptions
Company payments, 2023
$4,220
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul Nyirjesy was code 87210 (general laboratory), 452 times for 178 patients. In total Paul Nyirjesy billed 2,123 services in 22 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87210 General Laboratory | Office | 452 | 178 | $5.60 | $2,533 |
| 83986 Clinical Chemistry | Office | 435 | 273 | $3.47 | $1,509 |
| 99459 Office/Outpatient Services | Office | 370 | 252 | $17.87 | $6,611 |
| 99214 Office E&M - Established | Office | 249 | 182 | $99.42 | $25K |
| Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens | Office | 233 | 182 | $17.33 | $4,037 |
| 99213 Office E&M - Established | Office | 151 | 132 | $64.46 | $9,733 |
| Q0112 All potassium hydroxide (koh) preparations | Office | 87 | 75 | $5.64 | $491 |
| 99204 Office E&M - New | Office | 58 | 58 | $125.34 | $7,270 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 31 | $12.85 | $398 |
| 99205 Office E&M - New | Office | 17 | 17 | $158.78 | $2,699 |
By year: 2022 $48K for 1,273 services; 2023 $45K for 1,193 services; 2024 $63K for 2,123 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87210 General Laboratory | 452 | 178 | $5.60 | $2,533 |
| 83986 Clinical Chemistry | 435 | 273 | $3.47 | $1,509 |
| Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens | 233 | 182 | $17.33 | $4,037 |
| Q0112 All potassium hydroxide (koh) preparations | 87 | 75 | $5.64 | $491 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul Nyirjesy prescribed most often to Medicare patients was Estradiol, with 641 prescriptions and refills. In total Paul Nyirjesy wrote 1,359 Medicare prescriptions that cost $142K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 641 | 1,338 | 223 | $66K |
| Clobetasol Propionate Generic | 207 | 313 | 121 | $6,245 |
| Fluconazole Generic | 79 | 109 | 55 | $792 |
| Yuvafem Estradiol | 59 | 146 | 21 | $14K |
| Premarin Estrogens, Conjugated | 55 | 116 | 22 | $29K |
| Triamcinolone Acetonide Generic | 41 | 41 | 24 | $109 |
| Amitriptyline Hcl Generic | 37 | 92 | 13 | $941 |
| Gabapentin Generic | 24 | 67 | Under 11 | $860 |
| Clindamycin Phosphate Generic | 22 | 25 | 13 | $1,386 |
| Betamethasone Dipropionate Generic | 20 | 28 | 12 | $777 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 16 | 46 | Under 11 | $448 |
| Valacyclovir Valacyclovir Hcl | 16 | 40 | Under 11 | $1,840 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 16 | 21 | 12 | $761 |
| Halobetasol Propionate Generic | 15 | 24 | Under 11 | $1,037 |
| Nortriptyline Hcl Generic | 12 | 34 | Under 11 | $300 |
Brand drugs: 115 claims; generic drugs: 1,244 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Paul Nyirjesy $4,220 ($4,220 in general payments such as food, travel and fees) from 2 companies. The largest payer was Cepheid with $4,020.
| Company | Payments | Amount |
|---|---|---|
| Cepheid DHR | 3 | $4,020 |
| New American Therapeutics, Inc. | 1 | $200 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.